Drugs to combat HIV are about to become cheaper in developing countries. The
multinationals Glaxo Wellcome and Hoffmann-La Roche will supply drugs at cut
rates to Uganda, Côte d’Ivoire, Chile and Vietnam in a two-year pilot
initiative organised by the Joint UN Programme on HIV/AIDS. Virco, a Belgian
diagnostics company, will train local technicians to screen patients to work out
which drugs to use. “We want to demonstrate that it is workable and
sustainable,” says Joseph Saba, the initiative’s coordinator. The extent of the
discounts is still being worked out.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Autism may have two distinct subtypes that vary by brain activity
2
A quantum state that lasts forever may finally be within our grasp
3
Fully autonomous drones have killed human soldiers for the first time
4
Sperm have been made magnetic to allow IVF inside the body
5
Walking shark found in Papua New Guinea is new to science
6
The secrets to keeping your brain sharp in old age
7
Has the answer to life's origins been hiding in our cells all along?
8
A new measure of health is revolutionising how we think about ageing
9
Global map reveals the vast scale of underground fungal networks
10
Technology is changing our perspective on nature – at every scale
